ASCO 2026: FDA-Cleared AI Put to the Test

• June 3, 2026

Liquid Biopsy in Lung and Breast Cancer: Real World Tumour Profiling and Clinical Insights

Liquid biopsy is increasingly being adopted to support tumour profiling across cancer pathways, particularly where tissue is limited or results are needed quickly.

• March 18, 2026

• 1 min

Distribution and molecular drivers of the 21-gene recurrence score in early breast cancer with low, intermediate, and high estrogen receptor expression

• by Shuai Li, Jiahui Huang, Yifei Zhu, Jin Hong, Siji Zhu, Weiqi Gao, Ou Huang, Jianrong He, Weiguo Chen, Yafen Li, Xiaosong Chen, Kunwei Shen, Jiayi Wu

• April 30, 2026

Estimation of histopathological types from breast MRI findings using a large language model

• by Rie Kanasaki, Kazufumi Suzuki, Takami Ota, Sadako Akashi-Tanaka, Yoji Nagashima, Shuji Sakai

• April 14, 2026